Aprea Therapeutics Inc

-0.14 (-3.73%)
5:10:56 PM EDT: $3.75 +0.14 (+3.88%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)13.49M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.17 Million
Adjusted EPS-$0.77
See more estimates
10-Day MA$3.76
50-Day MA$4.20
200-Day MA$4.07
See more pivots

Aprea Therapeutics Inc Stock, NASDAQ:APRE

3805 Old Easton Road, Doylestown, Pennsylvania 18902
United States of America
Phone: +1.617.463.9385
Number of Employees: 9


Aprea Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the provision of cancer therapeutics. It is involved in the development and commercialization of novel cancer therapeutics that reactivate mutant p53 tumor suppressor protein. The company was founded by Vladimir Bykov, Klas Gota Wiman, Staffan Stromblad, Natalia Issaeva, Galina Selivanova, and Wen Jie Bao in 2002 and is headquartered in Doylestown, PA.